Dr. Gilles Besin is a visionary scientific executive whose career spans over 20 years at the forefront of RNA therapeutics and immunology. As Chief Scientific Officer at Orbital Therapeutics, he is redefining the landscape of next-generation RNA medicine through groundbreaking work in mRNA and circular RNA platforms. From leading vaccine development programs to spearheading major biotech acquisitions, Dr. Besin blends deep scientific expertise with strategic insight, positioning him as a driving force in translating cutting-edge research into real-world therapeutic solutions.

Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.